Found 79 matching trials
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). PHASE2 To learn if treatment with tiragolumab and atezolizumab before and after st...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer PHASE2 This study will evaluate the surgical safety and feasibility of atezolizuma...
Show More Location
City of Hope Cancer Center
Learn More & Join Trial
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA PHASE2 Among resectable biliary tract cancers (BTC) patients, surgery has historic...
Show More Location
Peing University Cancer Hospital
Learn More & Join Trial
Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab PHASE2 The primary objective of this randomized phase II trial is to evaluate the ...
Show More Learn More & Join Trial
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck PHASE2 To determine the effect of neoadjuvant atezolizumab alone or in combination...
Show More Status
Active Not Recruiting
Location
University of San Francisco, California
Learn More & Join Trial
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients PHASE1 The purpose of this study is to determine whether cytoreduction of bulky me...
Show More Location
The University of Kansas Medical Center
Learn More & Join Trial
Perioperative Immunotherapy for NSCLC (ECTOP-1030) PHASE2 This trial is a randomized, multicenter, open label phase II clinical study...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) PHASE3 This is a randomized, double-blinded study designed to evaluate the efficac...
Show More Learn More & Join Trial
Microbiome Immunotherapy Toxicity and Response Evaluation N/A This is a observational study to investigate how the microbiome correlates ...
Show More Location
Royal United Hospitals Bath NHS Foundation Trust
Learn More & Join Trial
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC PHASE2 This is a phase II trial of neoadjuvant and adjuvant atezolizumab with or w...
Show More Status
Active Not Recruiting
Location
University of California San Diego Moores Cancer Center
Learn More & Join Trial